P16+ (HPV+) OPSCC: A Surgical Approach to Management

Monday, October 19, 2026

11:00 AM - 12:00 PM PT

Location: 501AC

Panelist(s)

CW

Carey Burton Wood, MD

Assistant Professor Otolaryngology - Head and Neck Surgery
University of Tennessee Health Science Center
Memphis, Tennessee, United States
RJ

Ryan Jackson, MD

Associate Professory
Washington University School of Medicine, United States

Moderator(s)

Molly E. Heft Neal, MD

Assistant Professor
University of Michigan
Ann Arbor, MI, United States

Panelist(s)

WT

Wade L. Thorstad, MD

Professor of Radiation Oncology
Washington University School of Medicine
St. Louis, MO, United States

Disclosure(s):

Wade L. Thorstad, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Attendees can expect an in depth but accessible conversation surrounding selection criteria and strategies for surgical management of HPV Oropharyngeal Cancer patients. By including a Head and Neck Radiation Oncologist with many years of practice experience, this panel provides a unique approach to discussion of care for these patients.

Learning Objectives:

Understand the treatment options based on NCCN guidelines for p16+ OPSCC.
Describe the rationale and approach for surgically focused management of p16+ OPSCC.
Appreciate the major DOs and DONTs of p16+ OPSCC treatment, including the role of adjuvant therapy.